Exploring cutting-edge therapies for steroid-refractory acute graft-versus-host disease (SR-aGVHD) beyond ruxolitinib treatment.
Research reveals how CMV and Pneumocystis jirovecii form a deadly partnership in kidney transplant patients, creating a health crisis far more dangerous than either infection alone.
Exploring how humoral and mucosal antibody responses target RSV structural proteins in hematopoietic cell transplant recipients with compromised immune systems.